JOURNAL OF CELLULAR AND MOLECULAR MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2240133, encodeId=d6bd224013336, content=JCMM的审稿周期相对较长，从投稿到接收的时间通常在3个月左右。 该期刊主要关注生理学、细胞医学、分子生物学等领域，包括病理学、药理学、公共卫生、实验医学等多个方向。 内容范围：期刊涵盖细胞结构和功能、分子水平的疾病机制、信号传导通路等多个关键领域，关注细胞的结构、功能、信号传导以及分子医学在疾病治疗中的应用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 23:34:42 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244587, encodeId=9fe7224458e3d, content=我的妈呀，我见过的最高的版面费 5,210 美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Dec 23 23:29:36 CST 2024, time=2024-12-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260999, encodeId=05a522609997d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：为什么还在underreview！快3个月了！可以给编辑发消息催一催吗啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34229445637, createdName=ms5000000162292369, createdTime=Fri Apr 18 13:55:33 CST 2025, time=2025-04-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259701, encodeId=4ff62259e01b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：慢性肝病;临床 经验分享：想请教各位下，文章大修了，修回实验找师妹帮忙补的，可以在修回阶段加师妹共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11254748941, createdName=ttangmin, createdTime=Wed Apr 09 09:15:26 CST 2025, time=2025-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向：肿瘤 经验分享：Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2243712, encodeId=d3d52243e1255, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：Under review20天了，Review 那里的invitations 显示：There are no invitations at this time.是没有邀请到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28e48136826, createdName=ms7000001862843243, createdTime=Fri Dec 20 10:44:05 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251665, encodeId=a671225166524, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础医学;Cancer 经验分享：24.11.29投稿 24.12.20 minor revision 24.1.10修回 24.1.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca28482197, createdName=ms5000001645873174, createdTime=Wed Feb 12 19:00:35 CST 2025, time=2025-02-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210584, encodeId=e880221058430, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;验证 经验分享：跟大家分享一下我的投稿时间线（后续更新）： 投稿日期 Jan-13-2024 差不多两周左右送外审 UR持续了 到目前 June-18-2024 从UR状态变成了 Awaiting EIC Decision 希望后面能接受，持续更新状态中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7cb8119947, createdName=ms8000001936269816, createdTime=Tue Jun 18 22:27:43 CST 2024, time=2024-06-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2230746, encodeId=da9a2230e46b6, content=Awaiting Admin Processing两个月了，感觉编辑把我忘了，写信催过两次一点反应没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f24a6504605, createdName=ms8000001786184298, createdTime=Mon Oct 14 08:08:39 CST 2024, time=2024-10-14, status=1, ipAttribution=)]

2024-11-30 ms2000001788822132 来自上海

JCMM的审稿周期相对较长，从投稿到接收的时间通常在3个月左右。
该期刊主要关注生理学、细胞医学、分子生物学等领域，包括病理学、药理学、公共卫生、实验医学等多个方向。
内容范围：期刊涵盖细胞结构和功能、分子水平的疾病机制、信号传导通路等多个关键领域，关注细胞的结构、功能、信号传导以及分子医学在疾病治疗中的应用。

15 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240133, encodeId=d6bd224013336, content=JCMM的审稿周期相对较长，从投稿到接收的时间通常在3个月左右。 该期刊主要关注生理学、细胞医学、分子生物学等领域，包括病理学、药理学、公共卫生、实验医学等多个方向。 内容范围：期刊涵盖细胞结构和功能、分子水平的疾病机制、信号传导通路等多个关键领域，关注细胞的结构、功能、信号传导以及分子医学在疾病治疗中的应用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 23:34:42 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244587, encodeId=9fe7224458e3d, content=我的妈呀，我见过的最高的版面费 5,210 美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Dec 23 23:29:36 CST 2024, time=2024-12-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260999, encodeId=05a522609997d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：为什么还在underreview！快3个月了！可以给编辑发消息催一催吗啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34229445637, createdName=ms5000000162292369, createdTime=Fri Apr 18 13:55:33 CST 2025, time=2025-04-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259701, encodeId=4ff62259e01b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：慢性肝病;临床 经验分享：想请教各位下，文章大修了，修回实验找师妹帮忙补的，可以在修回阶段加师妹共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11254748941, createdName=ttangmin, createdTime=Wed Apr 09 09:15:26 CST 2025, time=2025-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向：肿瘤 经验分享：Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2243712, encodeId=d3d52243e1255, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：Under review20天了，Review 那里的invitations 显示：There are no invitations at this time.是没有邀请到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28e48136826, createdName=ms7000001862843243, createdTime=Fri Dec 20 10:44:05 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251665, encodeId=a671225166524, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础医学;Cancer 经验分享：24.11.29投稿 24.12.20 minor revision 24.1.10修回 24.1.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca28482197, createdName=ms5000001645873174, createdTime=Wed Feb 12 19:00:35 CST 2025, time=2025-02-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210584, encodeId=e880221058430, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;验证 经验分享：跟大家分享一下我的投稿时间线（后续更新）： 投稿日期 Jan-13-2024 差不多两周左右送外审 UR持续了 到目前 June-18-2024 从UR状态变成了 Awaiting EIC Decision 希望后面能接受，持续更新状态中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7cb8119947, createdName=ms8000001936269816, createdTime=Tue Jun 18 22:27:43 CST 2024, time=2024-06-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2230746, encodeId=da9a2230e46b6, content=Awaiting Admin Processing两个月了，感觉编辑把我忘了，写信催过两次一点反应没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f24a6504605, createdName=ms8000001786184298, createdTime=Mon Oct 14 08:08:39 CST 2024, time=2024-10-14, status=1, ipAttribution=)]

2024-12-23 秋思来自广东省

我的妈呀，我见过的最高的版面费 5,210 美元

16 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240133, encodeId=d6bd224013336, content=JCMM的审稿周期相对较长，从投稿到接收的时间通常在3个月左右。 该期刊主要关注生理学、细胞医学、分子生物学等领域，包括病理学、药理学、公共卫生、实验医学等多个方向。 内容范围：期刊涵盖细胞结构和功能、分子水平的疾病机制、信号传导通路等多个关键领域，关注细胞的结构、功能、信号传导以及分子医学在疾病治疗中的应用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 23:34:42 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244587, encodeId=9fe7224458e3d, content=我的妈呀，我见过的最高的版面费 5,210 美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Dec 23 23:29:36 CST 2024, time=2024-12-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260999, encodeId=05a522609997d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：为什么还在underreview！快3个月了！可以给编辑发消息催一催吗啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34229445637, createdName=ms5000000162292369, createdTime=Fri Apr 18 13:55:33 CST 2025, time=2025-04-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259701, encodeId=4ff62259e01b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：慢性肝病;临床 经验分享：想请教各位下，文章大修了，修回实验找师妹帮忙补的，可以在修回阶段加师妹共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11254748941, createdName=ttangmin, createdTime=Wed Apr 09 09:15:26 CST 2025, time=2025-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向：肿瘤 经验分享：Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2243712, encodeId=d3d52243e1255, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：Under review20天了，Review 那里的invitations 显示：There are no invitations at this time.是没有邀请到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28e48136826, createdName=ms7000001862843243, createdTime=Fri Dec 20 10:44:05 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251665, encodeId=a671225166524, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础医学;Cancer 经验分享：24.11.29投稿 24.12.20 minor revision 24.1.10修回 24.1.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca28482197, createdName=ms5000001645873174, createdTime=Wed Feb 12 19:00:35 CST 2025, time=2025-02-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210584, encodeId=e880221058430, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;验证 经验分享：跟大家分享一下我的投稿时间线（后续更新）： 投稿日期 Jan-13-2024 差不多两周左右送外审 UR持续了 到目前 June-18-2024 从UR状态变成了 Awaiting EIC Decision 希望后面能接受，持续更新状态中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7cb8119947, createdName=ms8000001936269816, createdTime=Tue Jun 18 22:27:43 CST 2024, time=2024-06-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2230746, encodeId=da9a2230e46b6, content=Awaiting Admin Processing两个月了，感觉编辑把我忘了，写信催过两次一点反应没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f24a6504605, createdName=ms8000001786184298, createdTime=Mon Oct 14 08:08:39 CST 2024, time=2024-10-14, status=1, ipAttribution=)]

2025-04-18 ms5000000162292369 来自四川省

审稿速度:6.0 | 投稿命中率:5.0
经验分享：为什么还在underreview！快3个月了！可以给编辑发消息催一催吗啊啊啊

7 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240133, encodeId=d6bd224013336, content=JCMM的审稿周期相对较长，从投稿到接收的时间通常在3个月左右。 该期刊主要关注生理学、细胞医学、分子生物学等领域，包括病理学、药理学、公共卫生、实验医学等多个方向。 内容范围：期刊涵盖细胞结构和功能、分子水平的疾病机制、信号传导通路等多个关键领域，关注细胞的结构、功能、信号传导以及分子医学在疾病治疗中的应用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 23:34:42 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244587, encodeId=9fe7224458e3d, content=我的妈呀，我见过的最高的版面费 5,210 美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Dec 23 23:29:36 CST 2024, time=2024-12-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260999, encodeId=05a522609997d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：为什么还在underreview！快3个月了！可以给编辑发消息催一催吗啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34229445637, createdName=ms5000000162292369, createdTime=Fri Apr 18 13:55:33 CST 2025, time=2025-04-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259701, encodeId=4ff62259e01b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：慢性肝病;临床 经验分享：想请教各位下，文章大修了，修回实验找师妹帮忙补的，可以在修回阶段加师妹共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11254748941, createdName=ttangmin, createdTime=Wed Apr 09 09:15:26 CST 2025, time=2025-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向：肿瘤 经验分享：Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2243712, encodeId=d3d52243e1255, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：Under review20天了，Review 那里的invitations 显示：There are no invitations at this time.是没有邀请到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28e48136826, createdName=ms7000001862843243, createdTime=Fri Dec 20 10:44:05 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251665, encodeId=a671225166524, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础医学;Cancer 经验分享：24.11.29投稿 24.12.20 minor revision 24.1.10修回 24.1.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca28482197, createdName=ms5000001645873174, createdTime=Wed Feb 12 19:00:35 CST 2025, time=2025-02-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210584, encodeId=e880221058430, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;验证 经验分享：跟大家分享一下我的投稿时间线（后续更新）： 投稿日期 Jan-13-2024 差不多两周左右送外审 UR持续了 到目前 June-18-2024 从UR状态变成了 Awaiting EIC Decision 希望后面能接受，持续更新状态中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7cb8119947, createdName=ms8000001936269816, createdTime=Tue Jun 18 22:27:43 CST 2024, time=2024-06-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2230746, encodeId=da9a2230e46b6, content=Awaiting Admin Processing两个月了，感觉编辑把我忘了，写信催过两次一点反应没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f24a6504605, createdName=ms8000001786184298, createdTime=Mon Oct 14 08:08:39 CST 2024, time=2024-10-14, status=1, ipAttribution=)]

2025-04-09 ttangmin 来自上海

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：慢性肝病;临床
经验分享：想请教各位下，文章大修了，修回实验找师妹帮忙补的，可以在修回阶段加师妹共一吗？

9 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240133, encodeId=d6bd224013336, content=JCMM的审稿周期相对较长，从投稿到接收的时间通常在3个月左右。 该期刊主要关注生理学、细胞医学、分子生物学等领域，包括病理学、药理学、公共卫生、实验医学等多个方向。 内容范围：期刊涵盖细胞结构和功能、分子水平的疾病机制、信号传导通路等多个关键领域，关注细胞的结构、功能、信号传导以及分子医学在疾病治疗中的应用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 23:34:42 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244587, encodeId=9fe7224458e3d, content=我的妈呀，我见过的最高的版面费 5,210 美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Dec 23 23:29:36 CST 2024, time=2024-12-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260999, encodeId=05a522609997d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：为什么还在underreview！快3个月了！可以给编辑发消息催一催吗啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34229445637, createdName=ms5000000162292369, createdTime=Fri Apr 18 13:55:33 CST 2025, time=2025-04-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259701, encodeId=4ff62259e01b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：慢性肝病;临床 经验分享：想请教各位下，文章大修了，修回实验找师妹帮忙补的，可以在修回阶段加师妹共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11254748941, createdName=ttangmin, createdTime=Wed Apr 09 09:15:26 CST 2025, time=2025-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向：肿瘤 经验分享：Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2243712, encodeId=d3d52243e1255, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：Under review20天了，Review 那里的invitations 显示：There are no invitations at this time.是没有邀请到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28e48136826, createdName=ms7000001862843243, createdTime=Fri Dec 20 10:44:05 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251665, encodeId=a671225166524, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础医学;Cancer 经验分享：24.11.29投稿 24.12.20 minor revision 24.1.10修回 24.1.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca28482197, createdName=ms5000001645873174, createdTime=Wed Feb 12 19:00:35 CST 2025, time=2025-02-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210584, encodeId=e880221058430, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;验证 经验分享：跟大家分享一下我的投稿时间线（后续更新）： 投稿日期 Jan-13-2024 差不多两周左右送外审 UR持续了 到目前 June-18-2024 从UR状态变成了 Awaiting EIC Decision 希望后面能接受，持续更新状态中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7cb8119947, createdName=ms8000001936269816, createdTime=Tue Jun 18 22:27:43 CST 2024, time=2024-06-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2230746, encodeId=da9a2230e46b6, content=Awaiting Admin Processing两个月了，感觉编辑把我忘了，写信催过两次一点反应没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f24a6504605, createdName=ms8000001786184298, createdTime=Mon Oct 14 08:08:39 CST 2024, time=2024-10-14, status=1, ipAttribution=)]

2023-11-26 水逆退散～来自广西

偏重的研究方向：肿瘤
经验分享：Awaiting ED Assignment 11-25

98 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240133, encodeId=d6bd224013336, content=JCMM的审稿周期相对较长，从投稿到接收的时间通常在3个月左右。 该期刊主要关注生理学、细胞医学、分子生物学等领域，包括病理学、药理学、公共卫生、实验医学等多个方向。 内容范围：期刊涵盖细胞结构和功能、分子水平的疾病机制、信号传导通路等多个关键领域，关注细胞的结构、功能、信号传导以及分子医学在疾病治疗中的应用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 23:34:42 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244587, encodeId=9fe7224458e3d, content=我的妈呀，我见过的最高的版面费 5,210 美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Dec 23 23:29:36 CST 2024, time=2024-12-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260999, encodeId=05a522609997d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：为什么还在underreview！快3个月了！可以给编辑发消息催一催吗啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34229445637, createdName=ms5000000162292369, createdTime=Fri Apr 18 13:55:33 CST 2025, time=2025-04-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259701, encodeId=4ff62259e01b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：慢性肝病;临床 经验分享：想请教各位下，文章大修了，修回实验找师妹帮忙补的，可以在修回阶段加师妹共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11254748941, createdName=ttangmin, createdTime=Wed Apr 09 09:15:26 CST 2025, time=2025-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向：肿瘤 经验分享：Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2243712, encodeId=d3d52243e1255, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：Under review20天了，Review 那里的invitations 显示：There are no invitations at this time.是没有邀请到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28e48136826, createdName=ms7000001862843243, createdTime=Fri Dec 20 10:44:05 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251665, encodeId=a671225166524, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础医学;Cancer 经验分享：24.11.29投稿 24.12.20 minor revision 24.1.10修回 24.1.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca28482197, createdName=ms5000001645873174, createdTime=Wed Feb 12 19:00:35 CST 2025, time=2025-02-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210584, encodeId=e880221058430, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;验证 经验分享：跟大家分享一下我的投稿时间线（后续更新）： 投稿日期 Jan-13-2024 差不多两周左右送外审 UR持续了 到目前 June-18-2024 从UR状态变成了 Awaiting EIC Decision 希望后面能接受，持续更新状态中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7cb8119947, createdName=ms8000001936269816, createdTime=Tue Jun 18 22:27:43 CST 2024, time=2024-06-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2230746, encodeId=da9a2230e46b6, content=Awaiting Admin Processing两个月了，感觉编辑把我忘了，写信催过两次一点反应没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f24a6504605, createdName=ms8000001786184298, createdTime=Mon Oct 14 08:08:39 CST 2024, time=2024-10-14, status=1, ipAttribution=)]

2023-10-05 ms5000002112458054 来自广东省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：免疫;炎症
经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊...

167 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240133, encodeId=d6bd224013336, content=JCMM的审稿周期相对较长，从投稿到接收的时间通常在3个月左右。 该期刊主要关注生理学、细胞医学、分子生物学等领域，包括病理学、药理学、公共卫生、实验医学等多个方向。 内容范围：期刊涵盖细胞结构和功能、分子水平的疾病机制、信号传导通路等多个关键领域，关注细胞的结构、功能、信号传导以及分子医学在疾病治疗中的应用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 23:34:42 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244587, encodeId=9fe7224458e3d, content=我的妈呀，我见过的最高的版面费 5,210 美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Dec 23 23:29:36 CST 2024, time=2024-12-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260999, encodeId=05a522609997d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：为什么还在underreview！快3个月了！可以给编辑发消息催一催吗啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34229445637, createdName=ms5000000162292369, createdTime=Fri Apr 18 13:55:33 CST 2025, time=2025-04-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259701, encodeId=4ff62259e01b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：慢性肝病;临床 经验分享：想请教各位下，文章大修了，修回实验找师妹帮忙补的，可以在修回阶段加师妹共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11254748941, createdName=ttangmin, createdTime=Wed Apr 09 09:15:26 CST 2025, time=2025-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向：肿瘤 经验分享：Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2243712, encodeId=d3d52243e1255, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：Under review20天了，Review 那里的invitations 显示：There are no invitations at this time.是没有邀请到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28e48136826, createdName=ms7000001862843243, createdTime=Fri Dec 20 10:44:05 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251665, encodeId=a671225166524, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础医学;Cancer 经验分享：24.11.29投稿 24.12.20 minor revision 24.1.10修回 24.1.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca28482197, createdName=ms5000001645873174, createdTime=Wed Feb 12 19:00:35 CST 2025, time=2025-02-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210584, encodeId=e880221058430, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;验证 经验分享：跟大家分享一下我的投稿时间线（后续更新）： 投稿日期 Jan-13-2024 差不多两周左右送外审 UR持续了 到目前 June-18-2024 从UR状态变成了 Awaiting EIC Decision 希望后面能接受，持续更新状态中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7cb8119947, createdName=ms8000001936269816, createdTime=Tue Jun 18 22:27:43 CST 2024, time=2024-06-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2230746, encodeId=da9a2230e46b6, content=Awaiting Admin Processing两个月了，感觉编辑把我忘了，写信催过两次一点反应没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f24a6504605, createdName=ms8000001786184298, createdTime=Mon Oct 14 08:08:39 CST 2024, time=2024-10-14, status=1, ipAttribution=)]

2024-12-20 ms7000001862843243 来自山东省

审稿速度:2.0
偏重的研究方向：肿瘤
经验分享：Under review20天了，Review 那里的invitations 显示：There are no invitations at this time.是没有邀请到审稿人吗？

26 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240133, encodeId=d6bd224013336, content=JCMM的审稿周期相对较长，从投稿到接收的时间通常在3个月左右。 该期刊主要关注生理学、细胞医学、分子生物学等领域，包括病理学、药理学、公共卫生、实验医学等多个方向。 内容范围：期刊涵盖细胞结构和功能、分子水平的疾病机制、信号传导通路等多个关键领域，关注细胞的结构、功能、信号传导以及分子医学在疾病治疗中的应用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 23:34:42 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244587, encodeId=9fe7224458e3d, content=我的妈呀，我见过的最高的版面费 5,210 美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Dec 23 23:29:36 CST 2024, time=2024-12-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260999, encodeId=05a522609997d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：为什么还在underreview！快3个月了！可以给编辑发消息催一催吗啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34229445637, createdName=ms5000000162292369, createdTime=Fri Apr 18 13:55:33 CST 2025, time=2025-04-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259701, encodeId=4ff62259e01b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：慢性肝病;临床 经验分享：想请教各位下，文章大修了，修回实验找师妹帮忙补的，可以在修回阶段加师妹共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11254748941, createdName=ttangmin, createdTime=Wed Apr 09 09:15:26 CST 2025, time=2025-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向：肿瘤 经验分享：Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2243712, encodeId=d3d52243e1255, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：Under review20天了，Review 那里的invitations 显示：There are no invitations at this time.是没有邀请到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28e48136826, createdName=ms7000001862843243, createdTime=Fri Dec 20 10:44:05 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251665, encodeId=a671225166524, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础医学;Cancer 经验分享：24.11.29投稿 24.12.20 minor revision 24.1.10修回 24.1.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca28482197, createdName=ms5000001645873174, createdTime=Wed Feb 12 19:00:35 CST 2025, time=2025-02-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210584, encodeId=e880221058430, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;验证 经验分享：跟大家分享一下我的投稿时间线（后续更新）： 投稿日期 Jan-13-2024 差不多两周左右送外审 UR持续了 到目前 June-18-2024 从UR状态变成了 Awaiting EIC Decision 希望后面能接受，持续更新状态中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7cb8119947, createdName=ms8000001936269816, createdTime=Tue Jun 18 22:27:43 CST 2024, time=2024-06-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2230746, encodeId=da9a2230e46b6, content=Awaiting Admin Processing两个月了，感觉编辑把我忘了，写信催过两次一点反应没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f24a6504605, createdName=ms8000001786184298, createdTime=Mon Oct 14 08:08:39 CST 2024, time=2024-10-14, status=1, ipAttribution=)]

2025-02-12 ms5000001645873174 来自安徽省

审稿速度:1.0
偏重的研究方向：肿瘤;基础医学;Cancer
经验分享：24.11.29投稿 24.12.20 minor revision 24.1.10修回 24.1.19接收

14 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240133, encodeId=d6bd224013336, content=JCMM的审稿周期相对较长，从投稿到接收的时间通常在3个月左右。 该期刊主要关注生理学、细胞医学、分子生物学等领域，包括病理学、药理学、公共卫生、实验医学等多个方向。 内容范围：期刊涵盖细胞结构和功能、分子水平的疾病机制、信号传导通路等多个关键领域，关注细胞的结构、功能、信号传导以及分子医学在疾病治疗中的应用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 23:34:42 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244587, encodeId=9fe7224458e3d, content=我的妈呀，我见过的最高的版面费 5,210 美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Dec 23 23:29:36 CST 2024, time=2024-12-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260999, encodeId=05a522609997d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：为什么还在underreview！快3个月了！可以给编辑发消息催一催吗啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34229445637, createdName=ms5000000162292369, createdTime=Fri Apr 18 13:55:33 CST 2025, time=2025-04-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259701, encodeId=4ff62259e01b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：慢性肝病;临床 经验分享：想请教各位下，文章大修了，修回实验找师妹帮忙补的，可以在修回阶段加师妹共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11254748941, createdName=ttangmin, createdTime=Wed Apr 09 09:15:26 CST 2025, time=2025-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向：肿瘤 经验分享：Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2243712, encodeId=d3d52243e1255, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：Under review20天了，Review 那里的invitations 显示：There are no invitations at this time.是没有邀请到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28e48136826, createdName=ms7000001862843243, createdTime=Fri Dec 20 10:44:05 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251665, encodeId=a671225166524, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础医学;Cancer 经验分享：24.11.29投稿 24.12.20 minor revision 24.1.10修回 24.1.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca28482197, createdName=ms5000001645873174, createdTime=Wed Feb 12 19:00:35 CST 2025, time=2025-02-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210584, encodeId=e880221058430, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;验证 经验分享：跟大家分享一下我的投稿时间线（后续更新）： 投稿日期 Jan-13-2024 差不多两周左右送外审 UR持续了 到目前 June-18-2024 从UR状态变成了 Awaiting EIC Decision 希望后面能接受，持续更新状态中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7cb8119947, createdName=ms8000001936269816, createdTime=Tue Jun 18 22:27:43 CST 2024, time=2024-06-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2230746, encodeId=da9a2230e46b6, content=Awaiting Admin Processing两个月了，感觉编辑把我忘了，写信催过两次一点反应没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f24a6504605, createdName=ms8000001786184298, createdTime=Mon Oct 14 08:08:39 CST 2024, time=2024-10-14, status=1, ipAttribution=)]

2024-06-18 ms8000001936269816 来自江西省

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;验证
经验分享：跟大家分享一下我的投稿时间线（后续更新）：
投稿日期 Jan-13-2024
差不多两周左右送外审 UR持续了
到目前 June-18-2024 从UR状态变成了 Awaiting EIC Decision
希望后面能接受，持续更新状态中。

90 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240133, encodeId=d6bd224013336, content=JCMM的审稿周期相对较长，从投稿到接收的时间通常在3个月左右。 该期刊主要关注生理学、细胞医学、分子生物学等领域，包括病理学、药理学、公共卫生、实验医学等多个方向。 内容范围：期刊涵盖细胞结构和功能、分子水平的疾病机制、信号传导通路等多个关键领域，关注细胞的结构、功能、信号传导以及分子医学在疾病治疗中的应用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 23:34:42 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244587, encodeId=9fe7224458e3d, content=我的妈呀，我见过的最高的版面费 5,210 美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Dec 23 23:29:36 CST 2024, time=2024-12-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260999, encodeId=05a522609997d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：为什么还在underreview！快3个月了！可以给编辑发消息催一催吗啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34229445637, createdName=ms5000000162292369, createdTime=Fri Apr 18 13:55:33 CST 2025, time=2025-04-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259701, encodeId=4ff62259e01b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：慢性肝病;临床 经验分享：想请教各位下，文章大修了，修回实验找师妹帮忙补的，可以在修回阶段加师妹共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11254748941, createdName=ttangmin, createdTime=Wed Apr 09 09:15:26 CST 2025, time=2025-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向：肿瘤 经验分享：Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2243712, encodeId=d3d52243e1255, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：Under review20天了，Review 那里的invitations 显示：There are no invitations at this time.是没有邀请到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28e48136826, createdName=ms7000001862843243, createdTime=Fri Dec 20 10:44:05 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251665, encodeId=a671225166524, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础医学;Cancer 经验分享：24.11.29投稿 24.12.20 minor revision 24.1.10修回 24.1.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca28482197, createdName=ms5000001645873174, createdTime=Wed Feb 12 19:00:35 CST 2025, time=2025-02-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210584, encodeId=e880221058430, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;验证 经验分享：跟大家分享一下我的投稿时间线（后续更新）： 投稿日期 Jan-13-2024 差不多两周左右送外审 UR持续了 到目前 June-18-2024 从UR状态变成了 Awaiting EIC Decision 希望后面能接受，持续更新状态中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7cb8119947, createdName=ms8000001936269816, createdTime=Tue Jun 18 22:27:43 CST 2024, time=2024-06-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2230746, encodeId=da9a2230e46b6, content=Awaiting Admin Processing两个月了，感觉编辑把我忘了，写信催过两次一点反应没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f24a6504605, createdName=ms8000001786184298, createdTime=Mon Oct 14 08:08:39 CST 2024, time=2024-10-14, status=1, ipAttribution=)]

2024-10-14 ms8000001786184298

Awaiting Admin Processing两个月了，感觉编辑把我忘了，写信催过两次一点反应没有

45 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务